1. Home
  2. Vaccines, Blood & Biologics
  3. ALTUVIIIO
  1. Vaccines, Blood & Biologics

ALTUVIIIO

STN: 125771
Proper Name: EFANESOCTOCOG ALFA (antihemophilic factor recombinant, Fc-VWF-XTEN fusion protein)
Tradename: ALTUVIIIO
Manufacturer: Bioverativ Therapeutics Inc.
Indication:

ALTUVIIIO [antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl] is a recombinant DNA-derived, Factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for:

  • Routine prophylaxis to reduce the frequency of bleeding episodes
  • On-demand treatment & control of bleeding episodes
  • Perioperative management of bleeding

Limitation of Use: 
ALTUVIIIO is not indicated for the treatment of von Willebrand disease.

Product Information

Supporting Documents

 

Back to Top